Used in pharmaceutical synthesis as a key intermediate in the preparation of bioactive molecules, particularly in the development of kinase inhibitors. Its boron-containing group enables participation in Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds. This makes it valuable in medicinal chemistry for constructing complex heterocyclic systems found in drug candidates. Commonly employed in research settings for the synthesis of potential therapeutic agents targeting cancer and inflammatory diseases.